NEW YORK (GenomeWeb) – In another sign of the life science community's increasing concern about antibody quality, a team led by Mathias Uhlén of the Royal Institute of Technology in Stockholm has formed a new working group to develop guidelines for validation and use of these reagents.

The International Working Group on Antibody Validation held its first meeting last month in Vancouver, Canada, coinciding with the Human Proteome Organization's annual meeting. According to Uhlén, it aims to have a set of guidelines it can present in a white paper at next year's HUPO meeting.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.